Abbvie ups Shire offer 11 percent to $51B; higher bid to come?
By Cormac Sheridan
Tuesday, July 8, 2014
DUBLIN UK investors were unmoved Tuesday by Abbvie Inc's improved cash-and-shares indicative offer for Shire plc, which values the specialty pharma firm at £30.1 billion (US$51.3 billion), or at £51.15 per share.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.